Native Bacterial and Viral Antigens Market

Native antigens are extracted in their natural form from the respective sources. As they undergo usual modifications in vivo, upon isolation, they exhibit close resemblance withthe complex 3-dimensional structure they exhibit in the host. In the case of protein antigens, these modifications may include post-translational alterations such as cleavage of precursor proteins, formation of disulphide bonds, and addition of low molecular weight groups through processes such as glycosylation or phosphorylation.

Native Bacterial and Viral Antigens Market contains market size and forecasts of Native Bacterial and Viral Antigens in Global, including the following market information:

Global Native Bacterial and Viral Antigens Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Native Bacterial and Viral Antigens market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chlamydia Antigens Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Native Bacterial and Viral Antigens include BIO-RAD LABORATORIES INC., Microbix Biosystems, SERION Immunologics, Aalto Bio Reagents Ltd, Enzo Life Sciences Inc., Jena Bioscience GmbH, ROSS SOUTHERN LABORATORIES, The Native Antigen Company and Creative Diagnostics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Native Bacterial and Viral Antigens companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Native Bacterial and Viral Antigens Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Native Bacterial and Viral Antigens Market Segment Percentages, by Type, 2021 (%)

Chlamydia Antigens

Adenovirus Antigens

Borrelia Antigens

Chikungunya Virus Antigens

Clostridium Antigens

Dengue Virus Antigens

Global Native Bacterial and Viral Antigens Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Native Bacterial and Viral Antigens Market Segment Percentages, by Application, 2021 (%)

ELISA

Immunoassay

SDS-PAGE

Hemagglutination

Agglutination Test

Global Native Bacterial and Viral Antigens Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Native Bacterial and Viral Antigens Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Native Bacterial and Viral Antigens revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Native Bacterial and Viral Antigens revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

BIO-RAD LABORATORIES INC.

Microbix Biosystems

SERION Immunologics

Aalto Bio Reagents Ltd

Enzo Life Sciences Inc.

Jena Bioscience GmbH

ROSS SOUTHERN LABORATORIES

The Native Antigen Company

Creative Diagnostics

TRINA BIOREACTIVES AG